Title of Collaborative Activity: |
Anti-Infective Drugs Advisory Committee |
Description of Collaborative Activity: |
This Committee provides expertise in the evaluation of evidence submitted by pharmaceutical companies to the FDA for drug approval. |
Type of Collaborative Activity: |
Advisory Group
|
Year the Collaborative Activity Originated: |
2007 |
NIH Participating Institutes/Centers/Office of the Director: |
NIAID |
HHS Agency Collaborators on this Activity: |
FDA |
